We believe you may hold MRK stock, as the company has one of the world's best-selling drugs in its portfolio that generates ...

The large inflow of cash from Comirnaty gross profits in 2021-22 has further secured BioNTech's financial health. Outside of BioNTech’s covid-19 vaccine candidates, we think the earliest approval ...

Cancer vaccines train the immune system to combat foreign invaders like tumours, enhancing the body's ability to recognize ...

A new chemotherapy regimen significantly boosts survival rates in cervical cancer patients and reduces the risk of death by ...

On September 10, experts across disciplines, from infectious disease clinicians to regulators to representatives from the pharmaceutical industry, convened at the inaugural ImmunOptimize workshop in ...

Oncologists are increasingly looking to oral sex as a primary driver of a steady rise in throat cancers. Rates of the disease ...

Immunotherapy and precision medicine show promise in better fighting cancer. What else does the research tell us?

And FDA said that Boston Scientific has again issued new instructions for its Obsidio Conformable Embolic after 15 injuries ...

The remarkable surge in the Intratumoral Cancer Therapies market is primarily attributed to the favorable regulatory ...

The biotech industry is buzzing with exciting changes, and a lot of it is thanks to one company: Moderna. Known for its COVID ...

INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases, today ...